Please login to the form below

Not currently logged in


This page shows the latest dermatology news and features for those working in and with pharma, biotech and healthcare.

AbbVie reports more solid data for would-be psoriasis blockbuster

AbbVie reports more solid data for would-be psoriasis blockbuster

A pair of phase III trials pitting risankizumab against Johnson &Johnson’s older IL-12/IL-23 inhibitor Stelara (ustekinumab) - reported at the American Academy of Dermatology meeting in Chicago over

Latest news

More from news
Approximately 11 fully matching, plus 179 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Royalty monetisation. 230. Jiangsu Hengrui Medicine/Arcutis. SHR0302, selective JAK inhibitor, for dermatology disorders (currently p2 for RA in China).

  • Pharma deals continue to slide Pharma deals continue to slide

    Roche has licensed a monoclonal antibody in phase II to Dermira, a dermatology company.

  • Deal Watch September 2016 Deal Watch September 2016

    The Vitae acquisition builds Allergan's dermatology pipeline with VTP-43742, a mid stage, orally active RORγt (retinoic acid receptor-related orphan receptor gamma) inhibitor for the potential treatment of psoriasis,

  • Deal Watch August 2016 Deal Watch August 2016

    So the product, which is an orphan drug, ended up in the portfolio of a $10bn company focussed on GI, dermatology and neurology and which was under investigation by the SEC

  • Deal Watch July 2016 Deal Watch July 2016

    Real Skin in the Game. Unusually there are several dermatology deals in July. ... Almirall is continuing to build the company's activities in dermatology, which now represents 43% of the company's revenues and is driving gross margin improvements.

More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...